Paris, 28 November 2017
Prescrire, along with around 20 civil society organisations, has signed a joint declaration drawing attention to potential problems posed by the provision of confidential scientific advice by the European Medicines Agency to pharmaceutical companies, especially a decline in regulatory standards, a risk of institutional capture, and a total lack of transparency surrounding the activity of European regulatory authorities.
Read more...
Brussels, 8 September 2017
33 civil society organisations, including Prescrire, acting together in the name of responsible pharmaceutial research and affordable medicines, called for the European Commission to abolish the mechanism of supplementary protection certificates (SPCs).
Read more...
Brussels, 18 May 2017
In a joint response to the EMA's consultation on its policy on access to documents, Health Action International, the International Society of Drug Bulletins, NoGracias, the Nordic Cochrane Centre and Prescrire called for a comprehensive public register of all the documents the EMA produces and receives. The coalition also strongly encourages the EMA to increase resources so it can more efficiently handle access requests to documents.
Read more...
Paris, 13 January 2017
In a joint response to the EU Commission Consultation on health technology assessment, Prescrire, the International Socety of Drug Bulletins and the Medicines in Europe Forum argue in favour of transparency, independence and high-quality evidentiary standards.
Read more...
13 September 2016
36 Civil Society Organisations have sent an Open letter to the European Commission urging the follow-up of the June 2016 EU Council Conclusions on "Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States »
Read more...
